Melanie Silinski, PhD, performs chemical analysis and supervises the daily activities of professional, technical, and clerical staff who work on projects that involve handling of chemicals. She has expertise in mass spectrometry and chromatography with applications in drug discovery and development, from early exploratory research through investigational new drugs.
Dr. Silinski serves as task leader for the National Toxicology Program project, which includes the chemical characterization of bulk chemicals being screened for toxicity/carcinogenesis, the analysis of dosage formulations, the analysis of biological samples, and stability studies of feed formulations used in animal studies. She reviews data and reports and regularly conducts Good Laboratory Practice studies for government and industrial clients.
Previously, Dr. Silinski worked as research investigator and scientist at Serenex and held research and teaching assistant positions at Duke University and Colgate University. She is a member of the American Association of Pharmaceutical Scientists, the American Society for Mass Spectrometry, the American Chemical Society, Phi Lambda Upsilon, Phi Beta Kappa, and Phi Eta Sigma.
